Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: henry jakala who wrote (1071)	6/18/1998 2:05:00 PM
From: Red Dragon	Respond to of 1115

Henry, you know my vote on your question. More deceptive statements? Note this sentence from the press release: In addition, 40 percent of LIDAKOL-treated patients experienced an aborted episode, meaning that after applying LIDAKOL Cream at the first symptoms of a recurrence, the blister did not form.'' Note that they did not bother to mention the "aborted" rate with placebo, or assign any statistical significance to the 40% rate of aborted episodes. Like Alan, I also have about 15 years of experience in medicine and biochemical research. The misleading and deceptive statements this company has repeatedly made (see my earlier posts in January) would never be accepted by anyone in the scientific community. But there are naive, uninformed investors who are willing to swallow the bait hook, line, and sinker.

To: henry jakala who wrote (1071)	6/18/1998 5:08:00 PM
From: luis a. garcia	Read Replies (1) \| Respond to of 1115

Henry management said plenty and did a press release on the 9 of this month that categorically says lidakol works and everything is fine and steady as she goes Henry this is no time to panic. They have a good plan going forward and the news should start getting more and more bullish in the future.. hold on tight. luis